» Articles » PMID: 37845360

Optimising a Urinary Extraction Method for Non-targeted GC-MS Metabolomics

Overview
Journal Sci Rep
Specialty Science
Date 2023 Oct 16
PMID 37845360
Authors
Affiliations
Soon will be listed here.
Abstract

Urine is ideal for non-targeted metabolomics, providing valuable insights into normal and pathological cellular processes. Optimal extraction is critical since non-targeted metabolomics aims to analyse various compound classes. Here, we optimised a low-volume urine preparation procedure for non-targeted GC-MS. Five extraction methods (four organic acid [OA] extraction variations and a "direct analysis" [DA] approach) were assessed based on repeatability, metabolome coverage, and metabolite recovery. The DA method exhibited superior repeatability, and achieved the highest metabolome coverage, detecting 91 unique metabolites from multiple compound classes comparatively. Conversely, OA methods may not be suitable for all non-targeted metabolomics applications due to their bias toward a specific compound class. In accordance, the OA methods demonstrated limitations, with lower compound recovery and a higher percentage of undetected compounds. The DA method was further improved by incorporating an additional drying step between two-step derivatization but did not benefit from urease sample pre-treatment. Overall, this study establishes an improved low-volume urine preparation approach for future non-targeted urine metabolomics applications using GC-MS. Our findings contribute to advancing the field of metabolomics and enable efficient, comprehensive analysis of urinary metabolites, which could facilitate more accurate disease diagnosis or biomarker discovery.

Citing Articles

Urine organic acid metabolomic profiling by gas chromatography mass spectrometry: Assessment of solvent extract evaporation parameters on the recovery of key diagnostic metabolites.

Carling R, Witek K, Emmett E, Gallagher C, Moat S Clin Chim Acta. 2024; 565:120015.

PMID: 39447825 PMC: 11876077. DOI: 10.1016/j.cca.2024.120015.


Validation of the Chemical and Biological Steps Required Implementing an Advanced Multi-Omics Approach for Assessing the Fate and Impact of Contaminants in Lagoon Sediments.

Mejait A, Fildier A, Giroud B, Daniele G, Wiest L, Raviglione D Metabolites. 2024; 14(8).

PMID: 39195550 PMC: 11356597. DOI: 10.3390/metabo14080454.


Metabolic insights into HIV/TB co-infection: an untargeted urinary metabolomics approach.

Olivier C, Luies L Metabolomics. 2024; 20(4):78.

PMID: 39014031 PMC: 11252185. DOI: 10.1007/s11306-024-02148-5.

References
1.
Isa F, Collins S, Lee M, Decome D, Dorvil N, Joseph P . Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis. EBioMedicine. 2018; 31:157-165. PMC: 6013777. DOI: 10.1016/j.ebiom.2018.04.014. View

2.
Kruve A, Leito I, Herodes K . Combating matrix effects in LC/ESI/MS: the extrapolative dilution approach. Anal Chim Acta. 2009; 651(1):75-80. DOI: 10.1016/j.aca.2009.07.060. View

3.
Burato J, Medina D, de Toffoli A, Maciel E, Lancas F . Recent advances and trends in miniaturized sample preparation techniques. J Sep Sci. 2019; 43(1):202-225. DOI: 10.1002/jssc.201900776. View

4.
Fiehn O . Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling. Curr Protoc Mol Biol. 2016; 114:30.4.1-30.4.32. PMC: 4829120. DOI: 10.1002/0471142727.mb3004s114. View

5.
Christou C, Gika H, Raikos N, Theodoridis G . GC-MS analysis of organic acids in human urine in clinical settings: a study of derivatization and other analytical parameters. J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 964:195-201. DOI: 10.1016/j.jchromb.2013.12.038. View